RZLT (Rezolute, Inc.) Short-Term Debt to Capital

Corporate company logo of Rezolute, Inc. (RZLT)

The daily price action for Rezolute, Inc. (RZLT) on the GURU.Markets platform is recorded at 0.01. Rezolute, Inc. (RZLT) is implementing AI algorithms and robotics to accelerate the discovery of therapeutic agents. The business focuses on developing drugs for orphan diseases, leveraging the global scaling of patents. High scientific authority and positive investor forecasts confirm the brand's significant potential.

Ratio of Short-Term Indebtedness to Capital: Rezolute Corp (RZLT) for 07/04/2022 - 10/30/2026

Analytical breakdowns for Rezolute, Inc.

- stock quotes and analyst forecast:
Stock Price Rezolute Corp|RZLT - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Rezolute Inc|RZLT - Enterprise Value
- book capitalization information:
Net Assets per Single Share Rezolute|RZLT - Accounting Value of Company|Market Value to Book Value Ratio rezolutebio.com|RZLT - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Rezolute, Inc.|RZLT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Rezolute|RZLT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Rezolute Inc|RZLT - Company Long-Term Liabilities|Company Short-Term Debts Rezolute|Quick Liquidity Indicator rezolutebio.com
- company profitability and valuation multiples indicators:
RZLT - Profit After Payment of Taxes
Fundamental valuation:RZLT Rezolute Corp
Brand item of Rezolute Inc

Investors must determine whether short-term liquidity risks outweigh the asset growth potential of Rezolute, Inc. (RZLT). When analyzing the current short-term debt-to-equity chart, one should evaluate the proportion of liabilities due within one year relative to equity, which, given the full control of partner manufacturing capacities, confirms financial stability during the development of new drug candidates.

Competitors of Rezolute, Inc.

Short-Term Debt to Capital ASND|MDGL (Madrigal Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CORT (Corcept Therapeutics)|Short-Term Debt to Capital rhythmtx.com RYTM|AKRO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital MTSR (Metsera, Inc.)|MoonLake Pharma (MLTX) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Crinetics Corp|NAMS (NewAmsterdam Pharma) - Short-Term Debt to Capital|Short-Term Debt to Capital soleno.life|Short-Term Debt to Equity Ratio FOLD (Amicus Therapeutics, Inc.)|ETNB (89bio Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Agios Pharmaceuticals Inc AGIO|GPCR - Short-Term Debt to Equity Ratio|MiMedx Group, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital lexpharma.com|MBX (MBX Biosciences) - Short-Term Debt to Equity Ratio|ALT: Short-Term Loans to Capital Ratio|AARD (Aardvark Therapeutics Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Sagimet Biosciences Inc|Short-Term Debt to Capital BIOA|Short-Term Debt to Equity BMEA (biomeafusion.com)|Short-Term Debt to Equity Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. (GUTS) - Current Liabilities to Capital|VTVT - Short-Term Debt to Equity|ATPC: Short-Term Debt to Equity|PLUR: Short-Term Debt to Capital|SYBX - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Lipocine|Matinas BioPharma Holdings Inc. (MTNB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Spruce Biosciences (SPRB)|Short-Term Debt to Equity Ratio Galecto Corporation GLTO|Short-Term Debt to Equity Carmell Corporation CTCX|Ratio of Short-Term Indebtedness to Capital LUMO|Organovo - Short-Term Debt to Capital|Current Liabilities to Capital Radius Recycling Inc.